Similar articles

• Effect of SK&F-12185 [dl-2(p-aminophenyl)-2-phenylethylamine] on adrenocortical function in primary aldosteronism.

  Gabrilove JL, Nicolis GL, Gallagher TF. Gabrilove JL, et al. J Clin Endocrinol Metab. 1967 Sep;27(9):1337-40. doi: 10.1210/jcem-27-9-1337. J Clin Endocrinol Metab. 1967. PMID: 6038874 No abstract available.
• Effect of DL-2(p-aminophenyl)-2-phenylethylamine on adrenocortical function in Cushing's syndrome due to nontumorous adrenocrotical hyperfunction.

  Gabrilove JL, Nicolis GL, Gallagher TF. Gabrilove JL, et al. J Clin Endocrinol Metab. 1967 Nov;27(11):1550-7. doi: 10.1210/jcem-27-11-1550. J Clin Endocrinol Metab. 1967. PMID: 6075585 No abstract available.
• [Corticosteroidogenesis inhibitors. II. A new cortico-adrenal inhibitor: amino-glutethimide (16,038Ba)].

  Philbert M, Luton JP, Mathieu de Fossey B, Bricaire H. Philbert M, et al. Presse Med (1893). 1968 May 11;76(23):1107-10. Presse Med (1893). 1968. PMID: 5657304 French. No abstract available.
• [Criteria for evaluating adrenal cortical reserves by the ACTH test].

  Khazanov MM. Khazanov MM. Probl Endokrinol (Mosk). 1972 Sep-Oct;18(5):110-8. Probl Endokrinol (Mosk). 1972. PMID: 4367011 Review. Russian. No abstract available.
• [Clinical findings and laboratory diagnosis in Cushing's syndrome].

  Staub JJ, Philbert M, Luton JP, Bricaire H. Staub JJ, et al. Praxis. 1968 Oct 15;57(41):1398-409. Praxis. 1968. PMID: 4307489 Review. German. No abstract available.